UNH - INVESTOR ALERT: DiCello Levitt LLP Announces Shareholder Class Action Against UnitedHealth Group Inc. (NYSE: UNH); Investors with Losses Encouraged to Seek Counsel | Benzinga
SAN DIEGO, May 24, 2024 (GLOBE NEWSWIRE) -- A class action lawsuit has been filed on behalf of purchasers or acquirers of UnitedHealth Group Inc. (NYSE:UNH) ("UnitedHealth" or the "Company") common stock between March 14, 2022 and February 27, 2024, inclusive (the "Class Period"), charging the Company and certain current and former senior executive officers with violations of the federal securities laws. UnitedHealth investors have until July 15 to seek appointment as lead plaintiff of the class action lawsuit.
If you purchased UnitedHealth common stock between March 14, 2022 and February 27, 2024, and suffered substantial losses, and you wish to obtain additional information or serve as lead plaintiff in this lawsuit, you may submit your information and contact us here: https://dicellolevitt.com/securities/unitedhealth-group/.
You can also contact DiCello Levitt partner Brian O'Mara by calling (888) 287-9005 or at investors@dicellolevitt.com.
No Case Has Been Filed and No Class Has Been Certified. Until a case is filed and a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice.
Case Allegations
UnitedHealth is a health care and well-being company comprised of two distinct and complementary businesses: Optum and UnitedHealthcare. UnitedHealthcare provides health insurance to individuals, employers, and small businesses and is the largest insurance provider in the United States. Optum provides healthcare-related services, including software solutions, payment services, and data analytics.
The UnitedHealth class action lawsuit alleges that on January 6, 2021, UnitedHealth announced an agreement to acquire Change Healthcare ("Change") and integrate it into its existing Optum business. On February ...
UNH); Investors with Losses Encouraged to Seek Counsel>Full story available on Benzinga.com